Overview
- 32 inspections across 32 sites are on record.
- 85 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-07-01.
At a glance
Inspections
32
Sites
32
Observations
85
Career since
Apr 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Baxter Healthcare Corporation | 1 Jul 2021 | Human Drugs | |
| Mylan Laboratories Limited | 28 Feb 2020 | Human Drugs | View 483 → |
| Somerset Therapeutics Private Limited | 19 Feb 2020 | Human Drugs | On file |
| Iacofano's Group LLC | 22 Jan 2020 | Foods & Cosmetics | View 483 → |
| Takeda Pharmaceutical Company Limited | 26 Nov 2019 | Human Drugs | View 483 → |
Sites inspected
Baxter Healthcare CorporationMarion, United States1 insp.
Mylan Laboratories LimitedBangalore, India1 insp.
Somerset Therapeutics Private LimitedBengaluru, India1 insp.
Iacofano's Group LLCCharleston, United States1 insp.
Takeda Pharmaceutical Company LimitedHikari, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Bonita S Chester4 shared
Linda F Murphy2 shared
Brett R Havranek2 shared
Melissa A Freeman2 shared
Frank J Marciniak2 shared
Michael R Klapal2 shared
Thomas J Arista2 shared
Helen B Ricalde2 shared
Shirley J Berryman2 shared
Margaret M Annes2 shared
Full investigator report
Get the verbatim findings behind Steven M Weinman's 85 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site